Lake Street Maintains Buy on Ekso Bionics Holdings, Lowers Price Target to $2
Portfolio Pulse from Benzinga Newsdesk
Lake Street analyst Ben Haynor maintains a Buy rating on Ekso Bionics Holdings but lowers the price target from $2.5 to $2.
October 29, 2024 | 5:10 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Lake Street analyst Ben Haynor maintains a Buy rating on Ekso Bionics Holdings but lowers the price target from $2.5 to $2.
The analyst's decision to maintain a Buy rating suggests confidence in the company's prospects, but the lowered price target indicates a more cautious outlook on its short-term valuation. This mixed signal may result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100